Simulations Plus Inc
Slēgts
SektorsVeselības aprūpe
18.42
Pārskats
Akcijas cenas izmaiņa
24h
Min
18.41
Max
18.42
Ienākumi | -960K 3.6M |
|---|---|
Pārdošana | -2.4M 22M |
P/E Sektora vidējais | 46.075 56.597 |
EPS | 0.3 |
Peļņas marža | 16.335 |
Darbinieki | 212 |
EBITDA | -6.3M 1.1M |
Tirgus kapitalizācija | 1.6M 373M |
|---|---|
Iepriekšējā atvēršanas cena | 18.42 |
Iepriekšējā slēgšanas cena | 18.42 |
Ziņu noskaņojums
By Acuity
50%
50%
146 / 339 Rangs Healthcare
Simulations Plus Inc Grafiks
Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.
Saistītās ziņas
Salīdzinājums
Cenas izmaiņa
Simulations Plus Inc Prognoze
Noskaņojums
By Acuity
146 / 339 Rangs Veselības aprūpe
Ziņu noskaņojums
Neutral
Volatilitāte
Zem vidējā
Ziņu apjoms (RCV)
Zem vidējā
Finanšu rādītāji
Pārdošanas un administrēšanas izmaksas
Darbības izmaksas
Peļņa pirms nodokļu nomaksas
Pārdošana
Pārdošanas maksa
Bruto peļņa no pārdošanas
Procentu izdevumi par parādu
EBITDA
Pamatdarbības peļņa
$
Par Simulations Plus Inc
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through Software and Services segments. It also offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. In addition, the company provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, and OBESITYsym products. Further, it offers Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Additionally, the company provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Furthermore, it offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.